Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Health In Tech has expanded its Enhanced Do-It-Yourself Benefit System (eDIYBS) to serve mid- and large-employer markets, significantly reducing underwriting timelines, as announced in a press release.
Formation Bio has announced the addition of four seasoned executives to its leadership team to enhance its AI-driven drug development efforts.
Penguin Ai has strengthened its executive team by appointing Mark Caron as Chief Strategy Officer and making several other key hires, following its Series A funding round.
FlyteHealth and Heartbeat Health have announced a strategic partnership to offer a unified virtual-first solution for cardiometabolic and cardiovascular care, as stated in a press release.
Micromedex has launched an AI-powered search tool to enhance clinical decision support for healthcare professionals, providing quick access to drug and toxicology information.
CTIBIOTECH's innovative bioprinted skin technology, featuring a sensory nervous system, received top honors at the IFSCC 2025 Congress in Cannes, France.
RevSpring has announced its acquisition of Kyruus Health, aiming to integrate provider data and patient engagement for a seamless healthcare experience.
Kipu Health has partnered with Team Recovery Technologies to integrate alumni engagement solutions into its platform, aiming to improve addiction treatment outcomes.
rater8 has introduced the rater8 Visibility Engine (raVE) to help healthcare providers maintain visibility in AI-driven search environments, as announced in a press release.
Bunkerhill Health has received FDA clearance for its AI algorithm, ECG-EF, which detects reduced ejection fraction from routine ECGs, enhancing early heart failure detection.
Heartline has introduced an AI-powered home health assistant to provide daily health check-ins and email summaries for family caregivers, announced in a press release.
SciBase has received an initial order for a clinical study from Castle Biosciences, marking the start of their collaboration to develop a test for atopic dermatitis.
TegMine Therapeutics has announced a strategic collaboration with Boehringer Ingelheim to advance its 2-Factor Antibody System for cancer treatment, as stated in a press release.
NextPlat Corp's ClearMetrx subsidiary is set to launch ClearMetrX 4.0, an AI-powered healthcare analytics software, in 2026, as announced in a press release.
HCAP Partners has announced its investment in Real Diagnostics, supporting Salt Creek Capital's acquisition and aiming to expand access to advanced diagnostic services.
Myriad Genetics and SOPHiA GENETICS have announced a strategic collaboration to develop a global liquid biopsy companion diagnostic test, leveraging Myriad's lab capabilities and SOPHiA's network.
Cionic has received FDA clearance for its Neural Sleeve 2, a wearable device that improves mobility by activating and relaxing muscles through AI-powered stimulation.
Capital Rx has rebranded as Judi Health and secured $400 million in funding to enhance its AI-driven health benefits platform, according to a press release.
DaltonTx, a UK-based tech company, has raised £4 million in seed funding to develop AI-enabled drug discovery platforms, announced in a press release.
Axtria and Kedaara Capital have completed a $240 million transaction, providing liquidity to employees and early investors.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
